Cellular Biology |
From the Department of Molecular & Integrative Physiology (T.J.H., R.V., E.F., L.M., T.E., J.M.M.) and Department of Internal MedicineCardiology (T.J.H. and J.M.M.), University of Michigan, Ann Arbor. Current address for R.V.: Brock University, St. Catharines, Ontario, Canada.
Correspondence to Todd J. Herron, PhD, Department of Molecular & Integrative Physiology, 1301 E Catherine St, University of Michigan, Ann Arbor, MI 48109-0622. E-mail toddherr{at}umich.edu
Increased relative expression of the slow molecular motor of the heart (ß-myosin heavy chain [MyHC]) is well known to occur in many rodent models of cardiovascular disease and in human heart failure. The direct effect of increased relative ß-MyHC expression on intact cardiac myocyte contractility, however, is unclear. To determine the direct effects of increased relative ß-MyHC expression on cardiac contractility, we used acute genetic engineering with a recombinant adenoviral vector (AdMYH7) to genetically titrate ß-MyHC protein expression in isolated rodent ventricular cardiac myocytes that predominantly expressed
-MyHC (fast molecular motor). AdMYH7-directed ß-MyHC protein expression and sarcomeric incorporation was observed as soon as 1 day after gene transfer. Effects of ß-MyHC expression on myocyte contractility were determined in electrically paced single myocytes (0.2 Hz, 37°C) by measuring sarcomere shortening and intracellular calcium cycling. Gene transfer-based replacement of
-MyHC with ß-MyHC attenuated contractility in a dose-dependent manner, whereas calcium transients were unaffected. For example, when ß-MyHC expression accounted for
18% of the total sarcomeric myosin, the amplitude of sarcomere-length shortening (nanometers, nm) was depressed by 42% (151.0±10.7 [control] versus 87.0±5.4 nm [AdMYH7 transduced]); and genetic titration of ß-MyHC, leading to 38% ß-MyHC content, attenuated shortening by 57% (138.9±13.0 versus 59.7±7.1 nm). Maximal isometric cross-bridge cycling rate was also slower in AdMYH7-transduced myocytes. Results indicate that small increases of ß-MyHC expression (18%) have Ca2+ transient-independent physiologically relevant effects to decrease intact cardiac myocyte function. We conclude that ß-MyHC is a negative inotrope among the cardiac myofilament proteins.
Key Words: adenovirus contractility gene transfer intracellular calcium muscle contraction myosin ventricular myocytes
This article has been cited by other articles:
![]() |
Y. Wen, J. R. Pinto, A. V. Gomes, Y. Xu, Y. Wang, Y. Wang, J. D. Potter, and W. G. L. Kerrick Functional Consequences of the Human Cardiac Troponin I Hypertrophic Cardiomyopathy Mutation R145G in Transgenic Mice J. Biol. Chem., July 18, 2008; 283(29): 20484 - 20494. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Day, P. Coutu, W. Wang, T. Herron, I. Turner, M. Shillingford, N. C. LaCross, K. L. Converso, L. Piao, J. Li, et al. Cardiac-directed parvalbumin transgene expression in mice shows marked heart rate dependence of delayed Ca2+ buffering action Physiol Genomics, May 9, 2008; 33(3): 312 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Banyasz, I. Lozinskiy, C. E. Payne, S. Edelmann, B. Norton, B. Chen, Y. Chen-Izu, L. T. Izu, and C. W. Balke Transformation of adult rat cardiac myocytes in primary culture Exp Physiol, March 1, 2008; 93(3): 370 - 382. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |